PX-478_685898-44-6_DataSheet_MedChemExpress

更新时间:2023-06-02 08:45:37 阅读: 评论:0

Product Name:
杀鸡PX-478CAS No.:
优质高效685898-44-6Cat. No.:
HY-10231MWt:
394.12Formula:
惠崇春江晚景翻译
C13H20Cl4N2O3Purity :>98%
Solubility:Mechanisms:一百五日夜对月
Biological Activity:
赛人References:
Caution: Not fully tested. For rearch purpos only
Medchemexpress LLC
<
养生茶配方[1]. Palayoor ST, et al. PX-478, an inhibitor of hypoxia-inducible factor-1alpha, enhances
radionsitivity of prostate carcinoma cells. Int J Cancer. 2008 Nov 15;123(10):2430-2437.[2]. Welsh S, et al. Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of
hypoxia-inducible factor-1alpha. Mol Cancer Ther. 2004 Mar;3(3):233-244.PX-478 is an inhibitor of HIF-1a with an IC50 of 20-30μM enhances radionsitivity of prostate
carcinoma cells.
日记IC50 value: 20-30 μM [1]
Target: HIF-1a in vitro: PX-478 enhances the radionsitivity of prostate carcinoma cells irradiated under normoxia. In addition to the inhibition of HIF-1a, treatment with PX-478 resulted in cell type-dependent alterations in cell cycle distribution and prolonged gH2AX expression in the irradiated cells. In PC3 cells, PX-478 significantly reduced the percentage of cells in G1 with an
accumulation of cells in S/G2M. [1]in vivo: PX-478 is an experimental HIF-1a inhibitor that has show
n antitumor activity against veral aggressive human tumor xenografts. [1] PX-478 shows antitumor activity against
established (0.15-0.40 cm3) human tumor xenografts with cures of SHP-77 small cell lung cancer and log cell kills up to 3.0 for
Pathways:Others; Target:HIF Product Data Sheet
个人工作不足10 mM in H2O (free soluble)
11 D e e r  P a r k  D r i v e , S u i t e  102D  M o n m o u t h  J u n c t i o n , N J  08852,U S A
E m a i l : i n f o @m e d c h e m e x p r e s s .c o m  W e b : w w w .m e d c h e m e x p r e s s .c o m

本文发布于:2023-06-02 08:45:37,感谢您对本站的认可!

本文链接:https://www.wtabcd.cn/fanwen/fan/82/832241.html

版权声明:本站内容均来自互联网,仅供演示用,请勿用于商业和其他非法用途。如果侵犯了您的权益请与我们联系,我们将在24小时内删除。

标签:翻译   工作   晚景   个人
相关文章
留言与评论(共有 0 条评论)
   
验证码:
推荐文章
排行榜
Copyright ©2019-2022 Comsenz Inc.Powered by © 专利检索| 网站地图